Indeed, NET formation in BD neutrophils is suppressed by colchicine and dexamethasone, which are clinically used for the treatment of BD as well as by Cl-amidine (a specific PAD4 inhibitor) and NAC (a ROS inhibitor) [60,64]. The gene discussed is PADI4; the disease is Behcet disease.